Zatorowość płucna
Zapobieganie i profilaktyka

Zatorowość płucna (PE) jest trzecią najczęstszą przyczyną zgonów sercowo-naczyniowych, powstającą najczęściej w wyniku migracji skrzepliny z żył głębokich kończyn dolnych do naczyń płucnych. Rocznie umiera z jej powodu około 100 000 osób, a nawet 600 000 Amerykanów doświadcza DVT lub PE. Kluczowa jest profilaktyka, oparta na identyfikacji pacjentów z grupy ryzyka, do której należą m.in. unieruchomienie, wiek >60 lat, otyłość, choroby nowotworowe, ciąża, stosowanie estrogenów, zabiegi chirurgiczne oraz palenie tytoniu. Ocena ryzyka odbywa się za pomocą narzędzi takich jak skala Capriniego czy algorytm QThrombosis, co umożliwia dobór odpowiedniej profilaktyki mechanicznej (pończochy uciskowe 15-30 mmHg, przerywany ucisk pneumatyczny, wczesna mobilizacja, elewacja kończyn) oraz farmakologicznej (LDUH 5000 j.m. co 8-12 h, LMWH, fondaparynuks 2,5 mg/d, DOACs, warfaryna, aspiryna). Filtry do żyły głównej dolnej stosuje się wyłącznie w wyjątkowych przypadkach z przeciwwskazaniami do leczenia przeciwkrzepliwego.

Profilaktyka Zatorowości Płucnej

Zatorowość płucna (PE) stanowi poważne, zagrażające życiu schorzenie, które powstaje najczęściej w wyniku przemieszczenia się skrzepliny z żył głębokich (najczęściej kończyn dolnych) do naczyń płucnych. Jest to trzecia co do częstości przyczyna zgonów z powodów sercowo-naczyniowych na świecie po udarze mózgu i zawale serca. Szacuje się, że rocznie z powodu zatorowości płucnej i jej powikłań umiera około 100 000 osób, a nawet 600 000 Amerykanów doświadcza zakrzepicy żył głębokich (DVT) lub zatorowości płucnej.1 Kluczowe znaczenie ma zatem skuteczna profilaktyka, której głównym celem jest zapobieganie powstawaniu zakrzepów w żyłach głębokich.23

Czynniki ryzyka zatorowości płucnej

Przed wprowadzeniem odpowiednich działań profilaktycznych niezbędna jest identyfikacja osób znajdujących się w grupie podwyższonego ryzyka wystąpienia zakrzepicy żył głębokich i zatorowości płucnej. Do głównych czynników ryzyka należą:45

  • Unieruchomienie (po zabiegach operacyjnych, długotrwałe pozostawanie w łóżku)
  • Długotrwałe podróże (powyżej 4-6 godzin)
  • Wiek powyżej 60 lat
  • Otyłość
  • Przebyte epizody zakrzepicy żylnej lub zatorowości płucnej
  • Choroby nowotworowe
  • Ciąża i okres połogu
  • Stosowanie doustnych środków antykoncepcyjnych zawierających estrogeny lub hormonalnej terapii zastępczej
  • Zabiegi chirurgiczne, szczególnie ortopedyczne i onkologiczne
  • Urazy, szczególnie kończyn dolnych i miednicy
  • Palenie tytoniu

678

Ocena ryzyka zakrzepowo-zatorowego

Kluczowym elementem profilaktyki jest właściwa ocena ryzyka wystąpienia powikłań zakrzepowo-zatorowych. W praktyce klinicznej stosowane są różne skale oceny ryzyka, z których najbardziej rozpowszechniona jest skala Capriniego.9 Pozwala ona na stratyfikację pacjentów do grup bardzo niskiego, niskiego, umiarkowanego i wysokiego ryzyka zakrzepicy, co umożliwia dobór odpowiedniej metody profilaktyki.10 Inne narzędzie to algorytm QThrombosis, który pozwala na ocenę absolutnego ryzyka żylnej choroby zakrzepowo-zatorowej w perspektywie 1 roku i 5 lat.11

Stratyfikacja ryzyka jest szczególnie istotna u pacjentów hospitalizowanych, zwłaszcza tych przechodzących zabiegi operacyjne. Ocena ta powinna być przeprowadzona u każdego pacjenta przyjmowanego do szpitala, ponieważ ryzyko wystąpienia DVT u hospitalizowanych pacjentów wynosi około 50%, co znacząco zwiększa ryzyko zatorowości płucnej.1213

Metody profilaktyki zatorowości płucnej

Profilaktyka zatorowości płucnej opiera się na dwóch głównych strategiach: zapobieganiu zastojowi żylnemu (metody mechaniczne) oraz zmniejszaniu krzepliwości krwi (profilaktyka farmakologiczna).3 Wybór odpowiedniej metody zależy od indywidualnej oceny ryzyka zakrzepicy u pacjenta oraz ryzyka krwawienia.14

Profilaktyka mechaniczna

Metody mechaniczne są szczególnie przydatne u pacjentów z przeciwwskazaniami do profilaktyki farmakologicznej lub jako uzupełnienie leczenia przeciwkrzepliwego u pacjentów z wysokim ryzykiem powikłań zakrzepowo-zatorowych.15 Do najczęściej stosowanych metod należą:

  • Pończochy uciskowe stopniowane (compression stockings) – wywierają kontrolowany ucisk na kończyny dolne, co poprawia przepływ krwi i zmniejsza jej zastój. Zalecane są pończochy zapewniające ucisk 15-30 mmHg na poziomie kostki.16 Są szczególnie przydatne podczas długotrwałych podróży oraz u pacjentów leżących.217
  • Przerywany ucisk pneumatyczny (intermittent pneumatic compression, IPC) – wykorzystuje mankiety napełniane powietrzem, które cyklicznie uciskają kończyny dolne, poprawiając przepływ krwi. Jest szczególnie zalecany po zabiegach operacyjnych i u pacjentów unieruchomionych.1819
  • Wczesne uruchamianie – mobilizacja pacjenta tak szybko, jak to możliwe po zabiegu operacyjnym lub w czasie choroby ograniczającej ruchomość.2021
  • Elewacja kończyn dolnych – uniesienie nóg o 4-6 cali (10-15 cm) podczas odpoczynku może poprawiać odpływ krwi żylnej.17

Profilaktyka farmakologiczna

Profilaktyka farmakologiczna jest zalecana u pacjentów z umiarkowanym i wysokim ryzykiem powikłań zakrzepowo-zatorowych, u których nie występują przeciwwskazania do stosowania leków przeciwkrzepliwych.14 Do najczęściej stosowanych leków należą:

  • Heparyna niefrakcjonowana w małych dawkach (low-dose unfractionated heparin, LDUH) – stosowana najczęściej w dawce 5000 j.m. podskórnie co 8-12 godzin.22
  • Heparyny drobnocząsteczkowe (low molecular weight heparin, LMWH) – np. enoksaparyna (Lovenox), dalteparyna, tinzaparyna – wykazują co najmniej taką samą skuteczność jak heparyna niefrakcjonowana przy mniejszym ryzyku krwawień i łatwiejszym dawkowaniu (zwykle raz na dobę).232425
  • Fondaparynuks – selektywny inhibitor czynnika Xa, stosowany w dawce 2,5 mg podskórnie raz na dobę, szczególnie u pacjentów po zabiegach ortopedycznych.26
  • Doustne antykoagulantywarfaryna oraz bezpośrednie doustne antykoagulanty (DOACs), takie jak rywaroksaban, apiksaban, dabigatran, edoksaban. DOACs są coraz częściej stosowane w profilaktyce ze względu na wygodę stosowania i brak konieczności monitorowania parametrów krzepnięcia.2728
  • Kwas acetylosalicylowy (aspiryna) – może być rozważany u wybranych pacjentów z niskim ryzykiem DVT, ale jego skuteczność jest niższa niż leków przeciwkrzepliwych. Badanie Pulmonary Embolism Prevention Trial (PEP) wykazało, że aspiryna w małej dawce zmniejsza ryzyko żylnej choroby zakrzepowo-zatorowej u pacjentów po złamaniu biodra oraz endoprotezoplastyce biodra i kolana.2918

Filtry przeciwzakrzepowe

Filtry do żyły głównej dolnej (inferior vena cava filters, IVCF) są czasami stosowane u pacjentów z wysokim ryzykiem zatorowości płucnej, u których występują przeciwwskazania do stosowania leków przeciwkrzepliwych lub u których doszło do nawrotowej zatorowości płucnej mimo prawidłowego leczenia przeciwkrzepliwego.3031 Filtry te nie zapobiegają powstawaniu zakrzepów, ale mogą zmniejszyć ryzyko zatorowości płucnej przez wychwytywanie skrzeplin przemieszczających się z kończyn dolnych.32 Należy jednak pamiętać, że zgodnie z wytycznymi ACCP z 2012 roku, filtry nie powinny być stosowane jako pierwotna metoda profilaktyki żylnej choroby zakrzepowo-zatorowej.3133

Profilaktyka w różnych grupach pacjentów

Profilaktyka u pacjentów chirurgicznych

Pacjenci poddawani zabiegom chirurgicznym są w grupie podwyższonego ryzyka powikłań zakrzepowo-zatorowych z powodu unieruchomienia, urazu tkanek i stanu nadkrzepliwości związanego z operacją.34 Zalecenia dotyczące profilaktyki obejmują:

  • Wczesne uruchamianie pacjenta – w miarę możliwości jak najszybciej po zabiegu operacyjnym.2119
  • Stosowanie profilaktyki farmakologicznej – u pacjentów z umiarkowanym i wysokim ryzykiem zaleca się stosowanie heparyn drobnocząsteczkowych, heparyny niefrakcjonowanej lub fondaparynuksu.35
  • Stosowanie metod mechanicznych – pończochy uciskowe, przerywany ucisk pneumatyczny, szczególnie u pacjentów z przeciwwskazaniami do profilaktyki farmakologicznej.36
  • U pacjentów po dużych zabiegach ortopedycznych (endoprotezoplastyka stawu biodrowego lub kolanowego) zaleca się przedłużoną profilaktykę przeciwzakrzepową przez 35 dni po operacji.27
  • U pacjentów onkologicznych poddawanych dużym zabiegom chirurgicznym w obrębie jamy brzusznej lub miednicy zaleca się przedłużoną profilaktykę farmakologiczną przez 4 tygodnie z użyciem heparyn drobnocząsteczkowych.3738

Badania wykazały, że stosowanie profilaktyki przeciwzakrzepowej po dużych zabiegach chirurgicznych może zmniejszyć częstość występowania zakrzepicy żył głębokich o 2/3 i zapobiec zgonom z powodu zatorowości płucnej u 1 na 200 pacjentów poddawanych dużym operacjom.39 W przypadku pacjentów poddawanych zabiegom neurochirurgicznym, ze względu na obawy o krwawienie wewnątrzczaszkowe, często stosuje się metody fizyczne (przerwany ucisk pneumatyczny i pończochy uciskowe), ale heparyny drobnocząsteczkowe stanowią akceptowalną alternatywę.27

Profilaktyka u pacjentów internistycznych

Pacjenci hospitalizowani z przyczyn internistycznych również znajdują się w grupie podwyższonego ryzyka powikłań zakrzepowo-zatorowych, szczególnie jeśli występuje u nich unieruchomienie, ostra niewydolność oddechowa, niewydolność serca, aktywna choroba nowotworowa lub zakażenia.15 Zalecenia obejmują:

  • Ocenę ryzyka żylnej choroby zakrzepowo-zatorowej u wszystkich hospitalizowanych pacjentów.36
  • Stosowanie profilaktyki farmakologicznej (heparyna niefrakcjonowana, heparyny drobnocząsteczkowe, fondaparynuks) u pacjentów z umiarkowanym i wysokim ryzykiem, o ile nie występują przeciwwskazania.4041
  • Stosowanie metod mechanicznych u pacjentów z przeciwwskazaniami do profilaktyki farmakologicznej.42
  • Wczesne uruchamianie pacjentów, gdy tylko jest to możliwe.43

U pacjentów hospitalizowanych z aktywną chorobą nowotworową i ostrą chorobą internistyczną lub ograniczoną ruchomością zaleca się stosowanie farmakologicznej profilaktyki przeciwzakrzepowej, o ile nie występują przeciwwskazania takie jak aktywne krwawienie.40

Profilaktyka podczas podróży

Długotrwałe podróże, szczególnie lotnicze, wiążą się ze zwiększonym ryzykiem żylnej choroby zakrzepowo-zatorowej, choć ryzyko bezwzględne jest niewielkie.44 Zalecenia dotyczące profilaktyki obejmują:4546

  • Regularne poruszanie się podczas podróży – wstawanie i chodzenie co godzinę.1647
  • Wykonywanie ćwiczeń mięśni łydek podczas siedzenia – zginanie i prostowanie stóp, krążenia stawami skokowymi.45
  • Wybór miejsca przy przejściu, które umożliwia łatwiejsze wstawanie i poruszanie się.16
  • Stosowanie pończoch uciskowych, szczególnie u osób z podwyższonym ryzykiem zakrzepicy.1648
  • Odpowiednie nawodnienie – picie dużej ilości wody, unikanie alkoholu i nadmiaru kofeiny.4549
  • Noszenie luźnej, wygodnej odzieży.4950

Dla podróżujących na długich dystansach (powyżej 4-6 godzin) ze znacznie zwiększonym ryzykiem żylnej choroby zakrzepowo-zatorowej (np. po niedawnym zabiegu chirurgicznym, z historią DVT/PE, w okresie poporodowym, z aktywną chorobą nowotworową) wytyczne American Society of Hematology sugerują stosowanie pończoch uciskowych lub profilaktycznych dawek heparyn drobnocząsteczkowych.1651

Profilaktyka w wybranych sytuacjach klinicznych

Profilaktyka u kobiet w ciąży i w okresie poporodowym

Ciąża i okres poporodowy wiążą się ze zwiększonym ryzykiem żylnej choroby zakrzepowo-zatorowej ze względu na zmiany w układzie krzepnięcia i ucisk mechaniczny macicy na naczynia żylne.21 Kobiety z wysokim ryzykiem rozwoju zakrzepicy (np. z przebytą zakrzepicą, trombofilią, otyłością) mogą wymagać profilaktyki przeciwzakrzepowej z użyciem heparyn drobnocząsteczkowych w czasie ciąży i po porodzie.6

Profilaktyka u pacjentów z nowotworami

Choroba nowotworowa jest istotnym czynnikiem ryzyka powikłań zakrzepowo-zatorowych. U pacjentów z aktywną chorobą nowotworową poddawanych zabiegom operacyjnym zaleca się stosowanie profilaktyki farmakologicznej z użyciem heparyny niefrakcjonowanej lub heparyn drobnocząsteczkowych, o ile nie występują przeciwwskazania związane z wysokim ryzykiem krwawienia.35 U pacjentów onkologicznych poddawanych dużym zabiegom chirurgicznym w obrębie jamy brzusznej lub miednicy zaleca się przedłużoną profilaktykę farmakologiczną przez 4 tygodnie.3852

Profilaktyka u pacjentów po urazach rdzenia kręgowego

Pacjenci po urazach rdzenia kręgowego znajdują się w grupie wysokiego ryzyka powikłań zakrzepowo-zatorowych ze względu na unieruchomienie i towarzyszące często inne urazy. U tych pacjentów zaleca się stosowanie kompleksowej profilaktyki łączącej przerwany ucisk pneumatyczny, pończochy uciskowe i heparyny drobnocząsteczkowe.4153 W przypadku pacjentów z bardzo wysokim ryzykiem można rozważyć czasowe założenie filtra do żyły głównej dolnej.41

Zmiana stylu życia w profilaktyce zatorowości płucnej

Poza metodami farmakologicznymi i mechanicznymi, istotną rolę w profilaktyce zatorowości płucnej odgrywają zmiany stylu życia:22054

  • Regularna aktywność fizyczna – zaleca się co najmniej 30 minut umiarkowanej aktywności fizycznej dziennie, co poprawia przepływ krwi i zmniejsza ryzyko tworzenia się zakrzepów.755
  • Utrzymywanie prawidłowej masy ciała – otyłość zwiększa ucisk na żyły kończyn dolnych, co może prowadzić do zastoju krwi i tworzenia się zakrzepów.256
  • Zaprzestanie palenia tytoniu – toksyczne substancje zawarte w papierosach uszkadzają naczynia krwionośne i zwiększają ryzyko zakrzepicy.577
  • Odpowiednie nawodnienie – picie wystarczającej ilości płynów zapobiega zagęszczeniu krwi i poprawia jej przepływ.5645
  • Unikanie długotrwałego unieruchomienia – podczas pracy siedzącej zaleca się wstawanie i krótkie spacery co 2 godziny.56
  • Konsultacja z lekarzem przed stosowaniem hormonalnej terapii zastępczej lub antykoncepcji hormonalnej, szczególnie u kobiet palących lub z nadwagą.576

Postępowanie w profilaktyce wtórnej

U pacjentów, którzy przebyli epizod zakrzepicy żył głębokich lub zatorowości płucnej, istotne jest zapobieganie nawrotom. Profilaktyka wtórna obejmuje:2043

  • Leczenie przeciwkrzepliwe – kontynuowane przez co najmniej 3 miesiące, a w przypadku nieprowokowanej zakrzepicy lub utrzymującego się czynnika ryzyka – nawet bezterminowo.85859
  • Regularne wizyty kontrolne u lekarza w celu dostosowania dawek leków przeciwkrzepliwych.43
  • Stosowanie pończoch uciskowych – w celu zapobiegania przewlekłej niewydolności żylnej po zakrzepicy.43
  • Modyfikacja stylu życia – regularna aktywność fizyczna, utrzymywanie prawidłowej masy ciała, zaprzestanie palenia tytoniu.8

Decyzja o długości trwania leczenia przeciwkrzepliwego powinna być zindywidualizowana, uwzględniając ryzyko nawrotu zakrzepicy oraz ryzyko krwawienia. U pacjentów z przejściowym czynnikiem ryzyka (np. unieruchomienie, zabieg operacyjny) zazwyczaj wystarczające jest 3-6 miesięcy leczenia przeciwkrzepliwego. Natomiast u pacjentów z nieprowokowaną zakrzepicą lub utrzymującym się czynnikiem ryzyka (np. aktywna choroba nowotworowa, trombofilia) może być konieczne bezterminowe leczenie przeciwkrzepliwe.6061

Edukacja i świadomość pacjentów

Kluczowym elementem skutecznej profilaktyki zatorowości płucnej jest edukacja pacjentów na temat czynników ryzyka, objawów oraz metod zapobiegania. Badania wykazują, że wielu pacjentów nie jest świadomych ryzyka związanego z żylną chorobą zakrzepowo-zatorową – około 46% ankietowanych pacjentów hospitalizowanych zgłosiło, że ich lekarz nie omówił z nimi ryzyka zakrzepicy związanego z hospitalizacją.62

Edukacja powinna obejmować:6336

  • Informowanie pacjentów o czynnikach ryzyka zakrzepicy
  • Nauczanie pacjentów rozpoznawania wczesnych objawów zakrzepicy żył głębokich i zatorowości płucnej
  • Instrukcje dotyczące wykonywania ćwiczeń kończyn dolnych podczas długotrwałego unieruchomienia
  • Wskazówki dotyczące prawidłowego stosowania pończoch uciskowych
  • Informacje o znaczeniu regularnej aktywności fizycznej, utrzymywania prawidłowej masy ciała i zaprzestania palenia tytoniu
  • Instrukcje dotyczące prawidłowego stosowania leków przeciwkrzepliwych (jeśli są zalecane)

Implementacja profilaktyki w szpitalach

Mimo istnienia jasnych wytycznych dotyczących profilaktyki żylnej choroby zakrzepowo-zatorowej, nadal obserwuje się niedostateczne stosowanie profilaktyki u pacjentów hospitalizowanych. Szacuje się, że tylko 40-50% pacjentów internistycznych i 60-75% pacjentów chirurgicznych otrzymuje odpowiednią profilaktykę przeciwzakrzepową.13 W celu poprawy tej sytuacji zaleca się:1234

  • Wdrożenie protokołów oceny ryzyka zakrzepicy u wszystkich pacjentów przyjmowanych do szpitala
  • Wykorzystanie systemów elektronicznych wspierających podejmowanie decyzji klinicznych
  • Regularne szkolenia personelu medycznego w zakresie profilaktyki powikłań zakrzepowo-zatorowych
  • Monitorowanie wskaźników stosowania profilaktyki przeciwzakrzepowej
  • Współpracę interdyscyplinarną między klinicystami, chirurgami, personelem pielęgniarskim i farmaceutami

Każdy szpital powinien mieć opracowaną formalną strategię zwiększającą stosowanie odpowiedniej profilaktyki przeciwzakrzepowej.12 Takie podejście może znacząco zmniejszyć częstość występowania żylnej choroby zakrzepowo-zatorowej nabytej w szpitalu.36

Podsumowanie i rekomendacje

Zatorowość płucna stanowi poważne zagrożenie dla zdrowia i życia, ale jest w dużej mierze możliwa do zapobieżenia. Skuteczna profilaktyka obejmuje:47964

  • Identyfikację pacjentów z grupy ryzyka za pomocą walidowanych narzędzi oceny
  • Dobór odpowiedniej metody profilaktyki (mechanicznej, farmakologicznej lub obu) w zależności od indywidualnego ryzyka zakrzepicy i krwawienia
  • Wczesne uruchamianie pacjentów po zabiegach operacyjnych i podczas chorób wymagających unieruchomienia
  • Stosowanie profilaktyki farmakologicznej u pacjentów z umiarkowanym i wysokim ryzykiem powikłań zakrzepowo-zatorowych
  • Stosowanie metod mechanicznych (pończochy uciskowe, przerywany ucisk pneumatyczny) jako uzupełnienie profilaktyki farmakologicznej lub alternatywę u pacjentów z przeciwwskazaniami do stosowania leków przeciwkrzepliwych
  • Modyfikację stylu życia, obejmującą regularną aktywność fizyczną, utrzymywanie prawidłowej masy ciała, zaprzestanie palenia tytoniu i odpowiednie nawodnienie
  • Edukację pacjentów na temat czynników ryzyka i metod zapobiegania zakrzepicy

Prawidłowo stosowana profilaktyka może zmniejszyć częstość występowania żylnej choroby zakrzepowo-zatorowej o około 70%.36 Biorąc pod uwagę, że zatorowość płucna jest główną przyczyną możliwych do uniknięcia zgonów szpitalnych, wdrożenie skutecznych strategii profilaktycznych powinno być priorytetem dla wszystkich placówek opieki zdrowotnej.139

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 PREVENTION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2430635/
    In May 2006, former U.S. Surgeon General Richard H. Carmona, in conjunction with the National Heart Lung and Blood Institute, hosted the Surgeon General’s Workshop on Deep Vein Thrombosis (DVT). The goal of this meeting was to raise awareness about DVT and Pulmonary Embolism (PE) and identify new areas of research related to venous biology, DVT, PE, their complications, and clinical interventions. […] DVT and PE result in many preventable deaths each year. Estimates suggest that at least 100,000 deaths may be directly or indirectly related to DVT and PE each year, with some 350,000, and perhaps as many as 600,000, Americans falling victim to DVT and PE annually. […] Many people do not know about the harmful effects of DVT and PE, and it is vital that word about this public health concern is spread throughout our nation.
  • #2 Preventing Pulmonary Embolism | NYU Langone Health
    https://nyulangone.org/conditions/pulmonary-embolism/prevention
    NYU Langone doctors offer advice on how to prevent pulmonary embolism, a serious blockage in the arteries of the lungs. […] The best way to prevent pulmonary embolism is to minimize the chance of developing blood clots and deep vein thrombosis. […] Leading an active lifestyle, quitting smoking, and staying as mobile as possible can decrease your risk of developing pulmonary embolism. […] Long car and plane rides may force you to sit in one position, but our doctors recommend that you find ways to move as much as possible. […] Our doctors also advise wearing compression stockings on long trips to help keep blood from pooling in the legs. […] People who are at risk of developing blood clots may be given anticoagulant, or blood-thinning, medications before and after any surgery. […] Being obese puts additional pressure on the veins in the legs, which can contribute to poor blood flow and the development of blood clots.
  • #3 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. DVT occurs mostly in the lower extremities and, to a lesser extent, in the upper extremities. Pulmonary embolism (PE) is an obstruction of the pulmonary artery or its branches by a thrombus (sometimes due to fat or air). The most likely source of thrombus in pulmonary arteries is an embolization from deep veins in the legs. This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity.
  • #4 How to reduce your risk of having a pulmonary embolism | Asthma + Lung UK
    https://www.asthmaandlung.org.uk/conditions/pulmonary-embolism/prevention
    In most cases, a pulmonary embolism happens when a blood clot travels up to your lungs from a vein in your body, usually in your leg. This is called a deep vein thrombosis (DVT). The blood clot causes a blockage in a blood vessel in your lungs. […] Some people are at a higher risk of DVT, which can cause a pulmonary embolism. This includes people who: […] There are also times when you’re at higher risk of a DVT. For example, if you’re on bed rest for more than five days, or go on a long flight, train or car journey that lasts for over three hours. […] But, if you do not move for a long time, the flow of blood around your body can slow and blood clots can form. This can cause a DVT that can break off and cause a pulmonary embolism. […] You can reduce your risk of blood clots by leading a healthier lifestyle. This includes:
  • #5 Pulmonary Embolism (PE) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism/pulmonary-embolism-pe
    Prevention of pulmonary embolism means prevention of deep venous thrombosis (DVT); the need depends on the patients risks, including […] Patients who are bedbound and hospitalized and patients undergoing surgical, especially orthopedic, procedures benefit significantly from venous thromboembolism prophylaxis, and most of these patients can be identified before a thrombus forms. Preventive measures include low-dose unfractionated heparin, low molecular weight heparin, warfarin, fondaparinux, direct oral anticoagulants (eg, rivaroxaban, apixaban), compression devices, and elastic compression stockings. […] The type of surgery as well as patient-specific factors determine the risk of DVT. Independent risk factors for surgical and nonsurgical patients include […] The Caprini score is commonly used for DVT risk stratification and determination of the need for DVT prophylaxis in nonorthopedic surgical patients.
  • #6 Prevention of Deep Vein Thrombosis & Pulmonary Embolism – Blood Clots
    https://www.stoptheclot.org/learn_more/prevention_of_thrombosis/
    Ask your doctor about need for blood thinners or compression stockings to prevent clots, whenever you go to the hospital […] Talk to your doctor about your risk of clotting whenever you take hormones, whether for birth control or replacement therapy, or during and right after any pregnancy […] May is Womens Health Month a time to put a spotlight on the fact that blood clot risks tied to estrogen-based birth control, pregnancy, postpartum recovery, and hormone therapy impact millions of women every year. […] If youre a woman with a history of blood clots, you might be asking: what does this mean for my birth control options? Hormones play an important role in blood clot risk, and some types of contraception like estrogen-containing pills, patches, or rings can raise that risk even further. Knowing whats safe (and whats not) is crucial for protecting your health.
  • #7 Deep vein thrombosis (DVT) – Symptoms & causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/symptoms-causes/syc-20352557
    Lifestyle changes may help prevent deep vein thrombosis. Try these strategies: […] Move your legs. If you’ve had surgery or have been on bed rest, try to move as soon as possible. Don’t cross your legs while sitting. Doing so can block blood flow. […] When traveling, take frequent breaks to stretch your legs. When on a plane, stand or walk occasionally. If you’re traveling by car, stop every hour or so and walk around. If you can’t walk, do lower leg exercises. Raise and lower your heels while keeping your toes on the floor. Then raise your toes while keeping your heels on the floor. […] Don’t smoke. Smoking increases the risk of DVT. […] Manage weight. Obesity is a risk factor for DVT. Regular exercise lowers the risk of blood clots. As a general goal, aim for at least 30 minutes of moderate physical activity every day. If you want to lose weight, maintain weight loss or meet specific fitness goals, you may need to exercise more.
  • #8 Pulmonary embolism: Symptoms, causes, risk factors, and treatment – Harvard Health
    https://www.health.harvard.edu/diseases-and-conditions/pulmonary-embolism-symptoms-causes-risk-factors-and-treatment
    A pulmonary embolism is a serious and potentially life-threatening condition, but there are ways to help prevent it. […] The best way to prevent pulmonary emboli is to prevent blood clots from forming. […] Preventing a pulmonary embolism also involves recognizing signs that a DVT may be forming, such as swelling in your leg or arm with or without pain. […] To help prevent a DVT that may lead to a PE, take breaks to walk around during car, plane, or train travel. Wearing compression stockings can help as well. […] You also can make some lifestyle changes to help lower your risk of a pulmonary embolism, such as eating healthy foods, being physically active, maintaining a healthy weight, and not smoking. […] People with a pulmonary embolism need to take an anticoagulant drug for at least three months (most doctors recommend six months). People who have blood abnormalities that put them at especially high risk of a second pulmonary embolism, and those who have had two or more separate episodes, may need to take an anticoagulant drug indefinitely.
  • #9 Fatal Pulmonary Embolism Prevention – Caprini Rsk Score – Venous Resource Center
    https://capriniriskscore.org/2020/01/20/fatal-pulmonary-embolism-prevention/
    Fatal pulmonary embolism is the number one preventable cause of death after surgery. […] Most fatal pulmonary emboli can be prevented using proper thrombosis prophylaxis given for the appropriate length of time based on the patients risk. […] This requires administration of prophylactic doses of anticoagulation following surgery, commonly heparin or low molecular weight heparin (LMWH), to patients who are at risk for developing fatal thrombi. […] One should remember that not all VTE events can be prevented with anticoagulant prophylaxis; however, most fatal events are avoided with these drugs. […] A thorough risk assessment for the individual patient is necessary for success. […] The Caprini score is recommended as one approach to achieve this goal. […] Fatal pulmonary emboli are the number one preventable complication postoperatively. […] Most fatal pulmonary emboli but not all non-fatal VTE events can be prevented with appropriate anticoagulant prophylaxis.
  • #10 Prevention and Management of Deep Vein Thrombosis and Pulmonary Embolism | Anesthesia Key
    https://aneskey.com/prevention-and-management-of-deep-vein-thrombosis-and-pulmonary-embolism/
    Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common, preventable perioperative complication occurring in up to 5% of noncardiac surgical patients. […] Prevention and treatment of VTE are therefore exceedingly important. […] The Caprini Score is a validated risk assessment tool developed to stratify patients into very low, low, moderate, and high-risk groups for developing DVT and thereby to guide the choice of prevention strategy. […] For patients who are at very low risk of VTE, the American College of Chest Physicians recommends neither mechanical nor chemoprophylaxis for DVT and instead suggests early ambulation as a means for prevention. […] For those at low risk of VTE, recommendations are to utilize mechanical prophylaxis alone.
  • #11 Pulmonary Embolism (PE) Treatment & Management: Approach Considerations, Thrombolysis for Pulmonary Embolism, Anticoagulation for Pulmonary Embolism
    https://emedicine.medscape.com/article/300901-treatment
    The QThrombosis algorithm is intended to identify currently asymptomatic adults at greatest future risk of venous thrombosis based on established risk factors. According to the study in which it was developed and validated, QThrombosis estimates the absolute risk of venous thrombosis at 1 year and 5 years into the future, information that can be used to guide prophylaxis and medication decisions.
  • #12 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT. […] Hospitalized patients are at increased risk of developing DVT (approximately 50%), increasing the risk of PE. PE is one of the most common but preventable causes of death in hospitalized patients. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods. All hospitals should have a formal strategy that increases compliance with DVT prophylaxis.
  • #13 Venous thromboembolism (VTE) prophylaxis – Symptoms, diagnosis and treatment | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/1087
    Thromboprophylaxis is the most important patient safety strategy in patients admitted to the hospital. Pulmonary embolism remains the leading cause of preventable in-hospital death. […] Although national and international thromboprophylaxis guidelines have repeatedly recommended thromboprophylaxis of patients admitted to the hospital, only 40% to 50% of medical patients and 60% to 75% of surgical patients receive adequate thromboprophylaxis. […] Venous thromboembolism (VTE) prophylaxis consists of pharmacologic and nonpharmacologic measures to diminish the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). […] About 51% of deep venous thrombi will embolize to the pulmonary vasculature, resulting in a PE.
  • #14 Prevention and Management of Deep Vein Thrombosis and Pulmonary Embolism | Anesthesia Key
    https://aneskey.com/prevention-and-management-of-deep-vein-thrombosis-and-pulmonary-embolism/
    Once patients enter the moderate and high-risk categories for VTE, chemoprophylaxis becomes the preferred method; however, the risk of bleeding must also be considered. […] Patients at moderate to high risk of developing VTE should receive chemoprophylaxis as long as their risk of bleeding is acceptably low. […] Regular surveillance with Doppler ultrasound and prophylactic placement of inferior vena cava (IVC) filters have been described as methods of screening and prevention of VTE.
  • #15 Pulmonary Embolism in Critically Ill Patients—Prevention, Diagnosis, and Management
    https://www.mdpi.com/2075-4418/14/19/2208
    Pulmonary embolism (PE) is recognized as a significant preventable cause of hospital morbidity and mortality. Critically ill patients treated in intensive care units (ICUs) are at high risk for thromboembolic disease, both deep vein thrombosis (DVT) and PE. Key factors contributing to this elevated risk include mechanical ventilation, prolonged immobilization, persistent inflammation, concurrent infection, and dysfunction of the coagulation system and endothelium. The presence of central venous catheters, along with the use of sedatives, paralytics, and vasopressors, further increases the likelihood of DVT. Despite this, ICU populations are often underrepresented in many of the studies that form the basis of current clinical guidelines. […] The importance of pharmaceutical thromboprophylaxis in promoting positive patient outcomes and preventing thromboembolism is well established. However, certain patient groups have absolute contraindications to anticoagulation. These contraindications include active bleeding or a high risk of bleeding, particularly intracranial hemorrhage, such as that seen in a recent traumatic brain injury or hemorrhagic stroke, where anticoagulation decisions must be made in consultation with a neurosurgeon or neurologist. Severe thrombocytopenia is another contraindication, though the precise platelet count threshold remains unclear. Current recommendations suggest that thromboprophylaxis be administered when the platelet count exceeds 50,000, although the supporting data are limited. In cases where the platelet count is between 20,000 and 50,000, prophylactic anticoagulation may be considered with caution and under close monitoring, with decisions individualized to the patient’s specific situation. […] For patients who cannot receive immediate pharmacological prophylaxis, mechanical prophylaxis, such as using intermittent pneumatic compression or graduated compression stockings, remains an option, with more evidence in support of intermittent pneumatic compression.
  • #16 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC
    https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism
    Graduated compression stockings (GCS) appear to reduce asymptomatic DVT in travelers and are generally well tolerated. Decisions regarding use of pharmacologic prophylaxis for long-distance travelers at high risk should be made on an individual basis. When the potential benefits of pharmacologic prophylaxis outweigh the possible adverse effects, anticoagulants rather than antiplatelet drugs (e.g., aspirin) are recommended. […] For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel (grade 2C: weak recommendations, low or very low-quality evidence). […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.
  • #17 Pulmonary embolism – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/syc-20354647
    Preventing clots in the deep veins in your legs will help prevent pulmonary embolisms. For this reason, most hospitals are aggressive about taking measures to prevent blood clots, including: […] Blood thinners (anticoagulants). These medicines are often given to people at risk of clots before and after surgery. Also, they’re often given to people admitted to the hospital with certain medical conditions, such as heart attack, stroke or complications of cancer. […] Compression stockings. Compression stockings steadily squeeze the legs, helping veins and leg muscles move blood more efficiently. They offer a safe, simple and inexpensive way to keep blood from pooling in the legs during and after surgery. […] Leg elevation. Elevating your legs when possible and during the night can be very effective. Raise the bottom of your bed 4 to 6 inches (10 to 15 cm) with blocks or books.
  • #18 PREVENTION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2430635/
    Those undergoing surgery should be monitored carefully for the development of a DVT; the associated lack of ambulatory movement raises the risk for DVT and PE. Patients need to be evaluated for the use of appropriate preventive measures. One prevention method that can be used for surgical patients is to administer Low Molecular Weight Heparin (LMWH). […] Another prophylactic measure is increasing the amount of ambulatory movement for postoperative patients. Walking increases the amount of blood flow in patients, leading to a decreased probability of blood clot formation. […] Additionally, intermittent pneumatic compression (IPC) can be used for patients who are wheelchair- or bed-bound. […] For some patients, taking up to 150 mg of aspirin a day is a good preventive measure because it acts as a blood thinner, allowing for fluid movement of blood throughout the body.
  • #19 Pulmonary embolism – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/syc-20354647
    Physical activity. Moving as soon as possible after surgery can help prevent pulmonary embolism and hasten recovery overall. This is one of the main reasons your nurse may push you to get up, even on your day of surgery, and walk despite pain at the site of your surgical incision. […] Pneumatic compression. This treatment uses thigh-high or calf-high cuffs that automatically inflate with air and deflate every few minutes. This massages and squeezes the veins in your legs and improves blood flow. […] The risk of blood clots developing while traveling is low but increases as long-haul travel increases. If you have risk factors for blood clots and you’re concerned about travel, talk with your health care provider. […] Your provider might suggest the following to help prevent blood clots during travel:
  • #20 Pulmonary Embolism | Deep Vein Thrombosis | MedlinePlus
    https://medlineplus.gov/pulmonaryembolism.html
    Preventing new blood clots can prevent PE. Prevention may include: […] Continuing to take blood thinners. It’s also important to get regular checkups with your provider, to make sure that the dosage of your medicines is working to prevent blood clots but not causing bleeding. […] Heart-healthy lifestyle changes, such as heart-healthy eating, exercise, and, if you smoke, quitting smoking. […] Using compression stockings to prevent deep vein thrombosis (DVT). […] Moving your legs when sitting for long periods of time (such as on long trips). […] Moving around as soon as possible after surgery or being confined to a bed.
  • #21 Patient education: Pulmonary embolism (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/pulmonary-embolism-beyond-the-basics/print
    In all cases, walking as soon as possible after surgery can decrease the risk of a blood clot. […] Extended travel — Prolonged travel (for example, taking a long airplane flight or car ride) appears to increase the risk of developing blood clots, although the risk is very small. There are a few tips that may be of benefit during extended travel (table 1).
  • #21 Patient education: Pulmonary embolism (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/pulmonary-embolism-beyond-the-basics/print
    PULMONARY EMBOLISM PREVENTION […] During hospitalization — Some people who are in the hospital, either for surgery (especially bone or joint surgery and cancer surgery) or because of a serious medical illness, may be given anticoagulants to decrease the risk of blood clots. Anticoagulants may also be given to females at high risk for venous thrombosis during and after pregnancy. […] In people who are hospitalized and have a moderate to low risk of blood clots, other preventive measures may be used. For example, some people are fitted with inflatable compression devices after surgery. These devices are worn around the legs during and immediately after surgery and periodically fill with air. These devices apply gentle pressure to improve circulation and help prevent clots. Compression stockings may also be recommended.
  • #22 DVT and Pulmonary Embolism: Part II. Treatment and Prevention | AAFP
    https://www.aafp.org/pubs/afp/issues/2004/0615/p2841.html
    Treatment goals for deep venous thrombosis include stopping clot propagation and preventing the recurrence of thrombus, the occurrence of pulmonary embolism, and the development of pulmonary hypertension, which can be a complication of multiple recurrent pulmonary emboli. […] Treatment for pulmonary embolism is similar to that for deep venous thrombosis. […] Subcutaneous heparin, LMW heparin, and warfarin have been approved for use in surgical prophylaxis. […] Elastic compression stockings are useful in patients at lowest risk for thromboembolism. […] Intermittent pneumatic leg compression is a useful adjunct to anticoagulation and an alternative when anticoagulation is contraindicated. […] The simplest approach to prophylaxis for venous thromboembolism is low-dose unfractionated heparin, 5,000 units administered subcutaneously every eight or 12 hours.
  • #23 Pulmonary Embolism (PE) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism/pulmonary-embolism-pe
    The need for DVT prophylaxis is based on the risk assessment score (see table Prophylaxis Based on Caprini Score). Appropriate preventive measures, ranging from early ambulation to use of heparin, depend on the total score. […] Medication therapy to prevent DVT is usually delayed until after surgery to help avoid intraoperative bleeding. However, preoperative prophylaxis is also effective. […] In general surgery patients, low dose unfractionated heparin is given for 7 to 10 days or until the patient is fully ambulatory. Patients who are immobilized and not undergoing surgery should also receive low dose unfractionated heparin until they are ambulatory. […] Low molecular weight heparin dosing for DVT prophylaxis depends on the specific medication (enoxaparin, dalteparin, tinzaparin). Low molecular weight heparins are at least as effective as low dose unfractionated heparin for preventing DVT and PE.
  • #24 DVT and Pulmonary Embolism: Part II. Treatment and Prevention | AAFP
    https://www.aafp.org/pubs/afp/issues/2004/0615/p2841.html
    However, LMW heparin has been shown to be as effective as unfractionated heparin for surgical prophylaxis of DVT over periods of seven to 10 days (with a possible dose-dependent advantage on bleeding complications) and appears to be at least as effective as warfarin in most postoperative settings. […] Intermittent pneumatic leg compression devices are useful adjuncts to anticoagulation, as well as alternatives in patients with significant contraindications to the use of anticoagulants. […] Measures shown to be effective in the prevention of DVT in surgical patients, depending on level of risk, are listed in Table 6.
  • #25 Prophylaxis of Deep Vein Thrombosis (DVT) & Pulmonary Embolism | Lovenox®
    https://www.lovenox.com/dvt-prophylaxis
    Lovenox treatment lowered the risk of deep vein thrombosis (DVT) which may lead to pulmonary embolism (PE). […] Lovenox has proven outcomes in once-daily dosing of medically ill patients, offering: […] Many hospitalized, acutely ill medical patients and surgical patients may develop DVT/PE as outpatients. […] Appropriate length of DVT prophylaxis begins in the hospital and may continue with outpatient therapy.
  • #26 Pulmonary Embolism (PE) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism/pulmonary-embolism-pe
    Fondaparinux 2.5 mg subcutaneously once a day is as effective as low molecular weight heparin for patients who have undergone orthopedic surgery and for patients with heparin-induced thrombocytopenia or some other situations, such as after major orthopedic surgery. […] Inferior vena cava filters, intermittent pneumatic compression (also known as sequential compression devices [SCD]), and graded elastic compression stockings may be used alone or in combination with medications to prevent PE. […] An inferior vena cava filter (IVCF) may help prevent PE in patients with DVT in the leg or pelvic vasculature, but IVCF placement may risk long-term complications. […] Because venous collaterals can develop, providing a pathway for emboli to circumvent long-standing IVCFs, and because filters occasionally thrombose, patients with recurrent DVT or nonmodifiable risk factors for DVT may still require anticoagulation.
  • #27 Pulmonary Embolism (PE) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism/pulmonary-embolism-pe
    After surgical procedures with a high incidence of DVT/PE, low dose unfractionated heparin, low molecular weight heparin, or adjusted-dose warfarin is recommended. […] After orthopedic surgery of the hip or knee, additional options include the direct oral anticoagulants rivaroxaban and apixaban. These medications are safe and effective and, unlike warfarin, they do not require laboratory tests to monitor the level of anticoagulation. […] For total hip arthroplasty, patients should continue to take anticoagulants for 35 days postoperatively. In selected patients at very high risk of both DVT/PE and bleeding, temporary placement of an IVCF is an option for prophylaxis. […] In patients undergoing elective neurosurgical procedures, the risk of DVT/PE is also high. Because of concern about intracranial bleeding, physical methods (SCDs and elastic stockings) have often been used in patients undergoing neurosurgery; however, low molecular weight heparin appears to be an acceptable alternative.
  • #28 Prevention and Treatment of Venous Thromboembolism | American Heart Association
    https://www.heart.org/en/health-topics/venous-thromboembolism/prevention-and-treatment-of-venous-thromboembolism-vte
    Be proactive. Ask for a risk assessment for VTE if you are admitted to the hospital or are having surgery. […] VTEs often are preventable, with strategies that stop the development of clots in people „at-risk.” […] Those at risk may take anti-clotting, or blood-thinning, medications or use mechanical devices such as compression stockings or compression devices. […] Getting out of bed quickly after surgery is also advised if possible. […] Consider compression. Use graduated compression stockings or massaging compression devices if recommended by your health care professional. […] Take prescribed medication. If you have a high risk of a blood clot and a low risk of bleeding, a low-dose, “blood-thinning” medicine may help. […] Wear compression socks during your travel. […] Anticoagulants, including injectables such as heparin or low molecular weight heparin, or tablets such as apixaban, betrixaban, dabigatran, rivaroxaban, edoxaban and warfarin (also called direct-acting oral anticoagulants or DOACs). […] Anticoagulant therapy generally will be the first line of treatment with thrombolytic or surgery occurring in rare instances.
  • #29 Pulmonary Embolism Prevention Trial – PEP
    https://www.acc.org/latest-in-cardiology/clinical-trials/2010/02/23/19/14/pep
    Pulmonary Embolism Prevention Trial (PEP) was a randomized clinical trial designed to test whether aspirin reduces in-hospital morbidity due to venous thromboembolism in high-risk patients undergoing surgery for hip fracture and elective hip or knee arthroplasty. […] Patients at high risk for venous thromboembolism receiving perioperative low-dose aspirin would have improved in-hospital morbidity and mortality from venous thromboembolism. […] This trial demonstrates that low-dose aspirin was associated with a reduction in in-hospital risk of venous thromboembolism in patients undergoing surgery for hip fracture and knee and hip arthroplasty.
  • #30 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention
    It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk (see table Risk of Deep Venous Thrombosis and Pulmonary Embolism). DVT prophylaxis begins with risk assessment. Risk, along with other factors, allows the proper preventive modality to be selected. Preventive measures include […] Prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant)(eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant) […] Inferior vena cava (IVC) filters do not prevent DVT but are sometimes placed in an attempt to prevent pulmonary embolism (PE). An IVC filter may be used to help prevent PE in patients with lower extremity DVT who have contraindications to anticoagulant therapy or in patients with recurrent DVT (or emboli) despite adequate anticoagulation. Despite widespread use of IVC filters, efficacy in preventing PE is unstudied and unproven.
  • #31 Perioperative Pulmonary Embolism Prevention and Treatment
    http://transpopmed.org/articles/tppm/tppm-2017-4-054.php
    An important update in the 2012 ACCP guideline is for patients in all risk groups, that recommend that an inferior vena cava filter should not be used as the primary VTE prevention method. […] VTE Prophylaxis should be started either preoperatively or promptly postoperatively, and continued at least until the patient is fully ambulatory based on FDA approved labeling.
  • #32 Deep Vein Thrombosis & Pulmonary Embolism | UC San Diego Health
    https://health.ucsd.edu/care/heart-vascular/deep-vein-thrombosis-pulmonary-embolism/
    Deep vein thrombosis (DVT) is a condition where blood clots form in the deep veins of the legs. […] A pulmonary embolism that does not resolve on its own can be life-threatening. For these cases, medication or surgery (rarely needed) is used to break up the clot. […] There are two goals of pulmonary embolism treatment: Keep the existing blood clot from causing damage and Prevent the formation of new clots. […] A pulmonary embolism is typically treated with anticoagulants, or „blood thinners.” […] While anticoagulants do not break up clots that have already formed, your body can usually dissolve clots on its own over time. […] Other forms of treatment may be necessary in cases when the pulmonary embolism causes critical illness or you are unable to take anticoagulant medicines. […] An IVC filter can be permanently or temporarily implanted. While an IVC filter cannot prevent new blood clots from forming, it can help prevent deep venous thrombosis from moving into your lungs.
  • #33 Percutaneous interventions for pulmonary embolism | EuroIntervention
    https://eurointervention.pcronline.com/article/percutaneous-interventions-for-pulmonary-embolism
    Pulmonary embolism (PE) is a serious medical condition that occurs when fragments of a venous thrombus are dislodged and occlude one or more pulmonary arterial vessels, resulting in high morbidity and mortality. To mitigate the risks associated with PE, it is critical to focus on prevention, early diagnosis, proper risk stratification, and optimal treatment. In the prevention of PE, percutaneous positioning of filters in the inferior vena cava is an established option for selected high-risk patients with conditions such as vein thrombosis or recurrent PE despite anticoagulation. […] Patients at a high risk of VTE and those who have contraindications to anticoagulant therapy (or who experience recurrent PE despite adequate anticoagulation) may be candidates for vena cava interruption, which involves the placement of a filter device that mechanically prevents the embolisation of venous clots in the pulmonary circulation.
  • #34 Prophylaxis for deep venous thrombosis and pulmonary embolism in surgery (Chapter 22) – Medical Management of the Surgical Patient
    https://www.cambridge.org/core/books/medical-management-of-the-surgical-patient/prophylaxis-for-deep-venous-thrombosis-and-pulmonary-embolism-in-surgery/7F7DD39DF9322A9E63034CFC1AF400C9
    Venous thrombosis is a major cause of disability and death in all patient populations. […] The purpose of this chapter is to review the pathophysiology of perioperative deep vein thrombosis (DVT), assess preoperative VTE risk and review the modalities of prophylaxis for preventing postoperative VTE in surgical patients. […] The pathophysiologic changes of stasis, intimal injury, and hypercoagulability predispose surgical patients to the development of DVT or PE. […] Anesthesia causes peripheral venous vasodilation, which results in increased venous capacitance and decreased venous return during the operative procedure. […] The Surgical Care Improvement Project selected the application of VTE prophylaxis as a nationally reported metric for preventing VTE. […] In a large multi-center study, 30,827 surgical patients were evaluated with respect to venous thromboembolism (VTE) risk and appropriate prophylaxis as recommended by the American College of Chest Physician (ACCP). […] This study showed that 19,842 surgical patients were considered at risk for VTE but only 11,613 (58.5%) received appropriate ACCP-recommended VTE prophylaxis.
  • #35 Venous Thromboembolism (VTE) Guidelines: 2021 ACCP (CHEST) Guidelines for Venous Thromboembolism, 2021 ESVS Venous Thrombosis Clinical Practice Guidelines, 2020 ASH Updated Recommendations for Management of VTE
    https://emedicine.medscape.com/article/1267714-guidelines
    Recommendations regarding perioperative VTE prophylaxis in patients with cancer undergoing surgery included the following: All patients with malignant disease undergoing major surgical intervention should be offered pharmacologic thromboprophylaxis with either unfractionated heparin (UFH) or LMWH unless contraindicated because of active bleeding, or high bleeding risk, or other contraindications. […] In patients undergoing major orthopedic surgery and increased risk of bleeding, an IPCD or no prophylaxis is suggested rather than pharmacologic treatment (grade 2C). […] In patients undergoing major orthopedic surgery, it is suggested not to use inferior vena cava (IVC) filter placement for primary prevention over no thromboprophylaxis in patients with an increased bleeding risk or contraindications to both pharmacologic and mechanical thromboprophylaxis (grade 2C).
  • #36 Venous Thromboembolism Prevention Clinical Care Standard | Australian Commission on Safety and Quality in Health Care
    https://www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard
    A patient at risk of VTE receives information and education about VTE and ways to prevent it tailored to their risks and needs, and shares in decisions regarding their VTE prevention plan. […] A patient’s VTE prevention plan is documented and communicated to all clinicians involved in their care. […] A patient requiring a VTE prevention plan is offered medicines and/or mechanical methods of VTE prevention according to a current, locally endorsed, evidence-based guideline taking into consideration the patient’s clinical condition and their preferences. […] During hospitalisation, a patient’s thrombosis and bleeding risk is reassessed and documented at intervals no longer than every seven days, whenever the patient’s clinical condition or goals of care change, and on discharge from hospital. […] A patient at risk of VTE following hospitalisation receives a written discharge plan or care plan before they leave hospital, which describes their ongoing, individualised care to prevent VTE following discharge.
  • #36 Venous Thromboembolism Prevention Clinical Care Standard | Australian Commission on Safety and Quality in Health Care
    https://www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard
    The Venous Thromboembolism Prevention Clinical Care Standard has been developed by the Commission to support clinicians and health services implement the delivery of high-quality care to prevent venous thromboembolism (VTE) acquired in hospital and following hospital discharge. […] Despite current efforts, evidence suggests that a large proportion of hospitalised patients are at risk of VTE, however many patients do not receive appropriate VTE prophylaxis. VTE prevention strategies have been shown to significantly reduce the incidence of VTE by about 70%. […] A patient potentially at risk of VTE (as determined by local hospital/unit policy) receives a timely assessment of VTE risk using a locally endorsed evidence-based tool to determine their need for VTE prevention. […] A patient assessed to be at risk of VTE has a prevention plan developed that balances the risk of thrombosis against the risk and consequences of bleeding (as an adverse effect of VTE prevention medicines).
  • #37 Perioperative Pulmonary Embolism Prevention and Treatment
    http://transpopmed.org/articles/tppm/tppm-2017-4-054.php
    All perioperative patients are at an increased risk of pulmonary embolism and venous thromboembolism. […] It is important that healthcare providers recognize perioperative PE and know prevention and treatment options. […] The American College of Chest Physicians (ACCP) published a series of VTE guidelines. A very important change in the ACCP 2012 guideline for the risk of PE with surgery is the emphasis in individualized assessment. […] The VTE prophylaxis protocol for patients with high risk patients recommends the use of either medication or physical methods that are effective for DVT prophylaxis and is considered as a primary prevention approach. […] With all primary VTE prevention in patients with high risks without major bleeding risk, pharmacology prevention is preferred. […] Patients at high risk for VTE undergoing abdominal or pelvic surgery for cancer, ACCP recommends extended-duration, postoperative, pharmacologic prophylaxis for 4 weeks with LMWH over limited-duration prophylaxis.
  • #38 Deep vein thrombosis and pulmonary embolism following lung resection – Kolokotroni – Shanghai Chest
    https://shc.amegroups.org/article/view/6465/html
    Deep vein thrombosis (DVT) and pulmonary embolism (PE) are common complications in cancer. […] For this reason, prophylactic treatment with low molecular weight heparin or unfractioned heparin and antiembolism stockings or intermittent pneumatic compression devices are widely recommended for patients at risk for VTE. […] Extended VTE prophylaxis may be considered as there is a risk of developing VTE post discharge. […] The majority of surgeons in the USA do provide pharmacological thromboprophylaxis to patients who undergo lung resection but they do not provide extended VTE prophylaxis post discharge. […] The American College of Chest Physicians (ACCP, 9th edition) and the American Society of Clinical Oncology guidelines recommend LMWH for all patients undergoing surgical procedures for cancer starting either preoperatively or as soon as possible after the procedure for at least 7-10 days, which may be extended for 4 weeks in high-risk patients with history of VTE, high BMI, or postoperative residual lesions.
  • #39 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism
    https://www.outcomes-umassmed.org/dvt/best_practice/
    For over a decade, we have been involved in projects to improve the use of prophylaxis for deep vein thrombosis (DVT) in Massachusetts hospitals. […] Each year, at least 50,000 and perhaps as many as 200,000 patients will die from blood clots that obstruct blood flow to their lungs (pulmonary embolism). The tragedy is that most of these problems could be avoided by simple, cost-effective measures. Use of modern methods of DVT prophylaxis will reduce the incidence of DVT during the postoperative period by two-thirds and will prevent death from pulmonary embolism in 1 patient out of every 200 major operations. […] Prophylaxis is preferred to treatment, as venous thromboembolism can be hard to diagnose and, in the case of PE, there is often no warning that the patient is at risk. Death due to PE is often immediate or occurs within 1 to 2 hours of onset. In high-risk groups of patients, it is more cost effective to protect against DVT and PE than to treat these conditions when they occur.
  • #40 Venous Thromboembolism (VTE) Guidelines: 2021 ACCP (CHEST) Guidelines for Venous Thromboembolism, 2021 ESVS Venous Thrombosis Clinical Practice Guidelines, 2020 ASH Updated Recommendations for Management of VTE
    https://emedicine.medscape.com/article/1267714-guidelines
    The second update on the ninth edition of the initial 2016 American College of Chest Physicians (CHEST) guidelines was published on August 2, 2021, for the antithrombotic therapy for venous thromboembolism (VTE) diseases, such as deep venous thrombosis (DVT) and pulmonary embolism (PE). […] For patients with low-risk PE, CHEST suggests outpatient treatment over hospitalization provided the patients have access to appropriate medication, outpatient follow-up and care, and have adequate home circumstances (strong recommendation). […] Recommendations regarding anticoagulation for VTE prophylaxis in hospitalized patients with cancer included the following: Hospitalized patients who have active malignancy and acute medical illness or reduced mobility should be offered pharmacologic thromboprophylaxis in the absence of bleeding or other contraindications.
  • #41 Pulmonary Embolism (PE) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/pulmonary-embolism/pulmonary-embolism-pe
    In patients with spinal cord injury or multiple trauma, limited data support the combination of SCDs, elastic compression stockings, and low molecular weight heparin to prevent DVT/PE. For patients at very high risk, a temporary IVCF may be considered. […] In acutely ill medical patients, low dose unfractionated heparin, low molecular weight heparin, or fondaparinux can be given. SCDs, elastic compression stockings, or both may be used when anticoagulants are contraindicated.
  • #42 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention
    Most of these patients can be identified and should receive DVT prophylaxis. […] DVT prophylaxis can involve one or more of the following: […] Pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants) […] The use of inferior vena cava filters should be avoided unless DVT has been confirmed, except in highly selected patients. […] For patients undergoing total knee replacement and some other patients at high risk in whom anticoagulants cannot be given because of a high risk of bleeding, IPC is also beneficial. […] Preventive treatment is also indicated for patients who have a major medical illnesses that require bed rest (eg, myocardial infarction, ischemic stroke, heart failure). Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated.
  • #43 Screening and Prevention of Pulmonary Embolism ? | Hematology-Oncology Associates of CNY
    https://www.hoacny.com/patient-resources/blood-disorders/what-pulmonary-embolism/screening-and-prevention-pulmonary
    Preventing pulmonary embolism (PE) begins with preventing deep vein thrombosis (DVT). Knowing whether you’re at risk for DVT and taking steps to lower your risk are important. […] Exercise your lower leg muscles if you’re sitting for a long time while traveling. […] Get out of bed and move around as soon as you’re able after having surgery or being ill. The sooner you move around, the better your chance is of avoiding a blood clot. […] Take medicines to prevent clots after some types of surgery (as your doctor prescribes). […] Follow up with your doctor. […] If you’ve already had DVT or PE, you can take more steps to prevent new blood clots from forming. Visit your doctor for regular checkups. Also, use compression stockings to prevent chronic (ongoing) swelling in your legs from DVT (as your doctor advises). […] Contact your doctor right away if you have any signs or symptoms of DVT or PE.
  • #44 Flying and Blood Clots: Safety, Risks, Prevention, and More
    https://www.healthline.com/health/blood-clots-and-flying
    Being immobile for a long time, such as during a long flight, can increase your risk of getting a blood clot. […] But you can do things to reduce the risk. […] With the right preparation, even people with a history of blood clots can enjoy air travel. […] You can take several steps to help reduce your risk for blood clots while flying. […] According to the 2021 guidelines by the American Society of Hematology (ASH), preventive medication and wearing compression socks are remedies more appropriate if you know you are at a higher risk of developing a blood clot. […] Preventing blood clots during airplane travel and other forms of travel is possible. […] Understanding your personal risk and learning preventive steps you can take during traveling can help. […] If you are currently being treated for a blood clot, or have recently completed treatment for one, talk with your doctor before boarding a flight.
  • #45 Pulmonary embolism – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/syc-20354647
    Drink plenty of fluids. Water is the best liquid for preventing dehydration, which can contribute to the development of blood clots. Avoid alcohol, which contributes to fluid loss. […] Take a break from sitting. Move around the airplane cabin once an hour or so. If you’re driving, stop every so often and walk around the car a couple of times. Do a few deep knee bends. […] Move in your seat. Bend and make circle movements with your ankles and raise your toes up and down every 15 to 30 minutes. […] Wear support stockings. Your provider may recommend these to help promote circulation and fluid movement in your legs. Compression stockings are available in a range of stylish colors and textures. There are even devices, called stocking butlers, to help you put on the stockings.
  • #46 What Is Pulmonary Embolism? Symptoms, Causes, Diagnosis, Treatment, and Prevention
    https://www.everydayhealth.com/blood-clots/pulmonary-embolism/guide/
    The best way to prevent a pulmonary embolism is to prevent blood clots in your deep veins. According to Mayo Clinic, preventive measures include: […] Blood Thinners These are typically prescribed post surgery and after a person has experienced a heart attack or stroke to prevent blood clots. […] Compression Stockings These improve blood flow in the legs. Talk to your doctor about what type of compression stockings to get and how to wear them. […] Elevating Legs if you are on bedrest or have limited mobility, such as after surgery, then elevating your legs is recommended. […] Returning to Physical Activity Do so as soon as you can following surgery. […] The risk of DVT and PE while traveling is quite low, but long-haul flights do increase the risk. […] If you’re at an increased risk of blood clots, talk to your doctor about steps you can take to stay safe during long-haul travel. These may include:
  • #47 PREVENTION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2430635/
    Individuals who will be taking long trips on planes, trains, and automobiles should exercise their lower extremities by standing up and walking around at regular intervals to increase the blood flow through their legs. […] Another important aspect of prevention is encouraging patients to share their family health history with their health-care providers. Family health history may help identify those individuals at high risk for DVT so that prevention measures can be identified and put into place. […] Therefore, it is imperative that clinicians and patients are aware of DVT and PE and what they can do to prevent them. […] I encourage you to become aware of the risk factors for and the serious consequences of DVT and PE. Early prevention, diagnosis, and treatment of DVT and PE are vital to decreasing the number of people who are affected or who die each year from these conditions.
  • #48 What Is Pulmonary Embolism? Symptoms, Causes, Diagnosis, Treatment, and Prevention
    https://www.everydayhealth.com/blood-clots/pulmonary-embolism/guide/
    Get up and walking around every hour on an airplane. On a road trip, stop every so often to get out of your car and walk around. […] Stay hydrated by drinking plenty of fluids, especially water. Avoid alcohol, which can lead to dehydration. […] Wear compression stockings, which can improve blood flow in your legs. […] Move your legs in your seat with circular ankle movements and toe raises every 15 to 30 minutes.
  • #49 Pulmonary embolism
    https://www.nhs.uk/conditions/pulmonary-embolism/
    A pulmonary embolism often happens when part of the blood clot dislodges itself from your leg and travels up to your lungs, causing a blockage. […] There are measures you can take to lower your risk of getting a pulmonary embolism. […] If you’re being treated in hospital for another condition, your medical team should take steps to prevent DVT (deep vein thrombosis). […] A DVT can occasionally develop on long journeys such as bus, train or air travel. The risk of developing DVT is increased for flights lasting more than 4 hours. […] There are things you can do to reduce your risk of getting a travel-related DVT. […] sit comfortably in your seat and choose an aisle seat if possible […] wear loose-fitting clothing […] make sure you have plenty of leg room […] drink water regularly
  • #50 Pulmonary Embolism Types, Symptoms and Prevention
    https://larkinhealth.com/en/treatments-services/vascular/pulmonary-embolism/
    Prevent Deep Vein Thrombosis (DVT): Most people do not know that DVT usually causes PEs. Hence, it is crucial to take ample steps to prevent DVT. For instance, if you have had surgery for any other condition recently, take steps to prevent you from getting DVT under the doctor’s guidance. You should move around or do leg exercises as soon as you get a green signal from a doctor after surgery. […] Travel-related DVT on long-haul journeys can be prevented by wearing loose, comfortable clothes. Try doing leg stretching exercises while sitting, drinking ample water, wearing flight socks, and walking whenever possible.
  • #51 Deep Vein Thrombosis – Fit for Travel
    https://www.fitfortravel.nhs.uk/advice/general-travel-health-advice/deep-vein-thrombosis
    Long distance travel is a risk factor in the development of blood clots. […] Although the absolute risk of developing DVT or PE after a long haul flight is very small, the risk is increased if you have pre-existing risk factors. […] If you are at an increased risk of DVT or PE, anti-embolism stockings (AES) might be recommended to reduce your risk. […] Low molecular weight heparin can be considered for those at higher risk of developing DVT (see above).
  • #52 A study of pulmonary embolism after abdominal surgery in patients undergoing prophylaxis
    https://www.wjgnet.com/1007-9327/full/v15/i3/344.htm
    AIM: To determine risk factors for pulmonary embolism and estimate effects and benefits of prophylaxis. […] RESULTS: The incidence of pulmonary embolism after major abdominal surgery in patients who had received the prophylaxis was significantly lower compared to the subjects with the same condition who had not received any prophylaxis (P 0.001, OR = 2.825; 95% CI, 1.811-4.408). […] CONCLUSION: Prophylaxis with low molecular weight heparin is highly recommended during the preoperative period in patients with diagnosis of colorectal cancer due to high risk of pulmonary embolism after elective surgery. […] Prophylaxis with LMWH leads to effective reductions in the incidence of DVT after abdominal surgery in patients at risk for thromboembolic complications. […] In our study, patients who received prophylaxis with low dose LMWH after major abdominal surgery did not have any side effects (such as bleeding). Moreover, incidence of PE was significantly lower compared to subjects with the same conditions who did not receive prophylaxis. […] In our study, older age ( 60 years) was identified to be a risk factor for PE. Prophylaxis with LMWH is highly recommended for patients with colorectal cancer before major surgery.
  • #53 Prophylaxis of venous thrombosis and pulmonary embolism in patients with acute traumatic spinal cord lesions | Spinal Cord
    https://www.nature.com/articles/sc197631
    Twenty-one patients with acute traumatic spinal cord lesions who were admitted to our Spinal Unit during 1974 have been treated with Calcium Heparin, using a dosage of 5000-7500 i.u. at 12-hourly intervals from the first days after the lesion until the use of a wheelchair, as a prophylactic measure in order to prevent venous thromboembolism. […] We consider this technique to be very useful in the prophylaxis of thrombo-embolic complications in this type of patient. […] The prophylactic use of anticoagulant therapy in the prevention of pulmonary emboli in one hundred consecutive spinal injury patients.
  • #54 Pulmonary Embolism: Symptoms & Prevention – Victor Chang Cardiac Research Institute
    https://www.victorchang.edu.au/heart-disease/pulmonary-embolism
    The best way to prevent pulmonary embolism is to reduce your risk of developing DVT. […] Reducing your risk of DVT may include: maintaining a healthy diet, exercising regularly, regularly moving your arms and legs if sitting or standing for long periods (including on long-haul flights), managing your weight, quitting smoking, drinking plenty of water, talking to your doctor if you have a family history of blood clots, following any blood clot prevention strategies as advised by your doctor.
  • #55 Pulmonary Embolism: Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/17400-pulmonary-embolism
    Can a pulmonary embolism be prevented? Yes, you may be able to prevent it. Ways to prevent a pulmonary embolism include: Getting regular physical activity. If you cant walk around, move your arms, legs and feet for a few minutes every hour. If you know youll need to sit or stand for long periods, wear compression stockings to encourage blood flow. […] Talking to your provider about reducing your risk factors, especially if you or any of your family members have had a blood clot. […] Talking to your provider about a vena cava filter.
  • #56 Pulmonary Embolism Types, Symptoms and Prevention
    https://larkinhealth.com/en/treatments-services/vascular/pulmonary-embolism/
    It is possible to reduce the overall risk of blood clotting by making some healthy and positive changes in life and leading a healthier lifestyle: […] Quit Smoking: This is the foremost step you should take if you are a smoker. It can make a massive difference to your health. […] Stay Active: It is essential to exercise regularly, at least five days a week. You can start by adding a daily walking/jogging routine, yoga, or aerobics. […] Avoid Sitting for Too Long: Most individuals doing desk jobs are prone to develop pulmonary embolism. Set an alarm and get up every 2 hours for at least 15 minutes. […] Drink Up: Drink at least 8-10 glasses of water daily to avoid dehydration. […] Lose Weight: This is important if you are overweight or obese. Maintaining a healthy weight by eating a healthy balanced diet and cutting down sugar and unhealthy fats from the daily diet.
  • #57 Preventing Pulmonary Embolism | NYU Langone Health
    https://nyulangone.org/conditions/pulmonary-embolism/prevention
    Toxic chemicals in cigarettes harm blood cells and blood vessels and make you more susceptible to deep vein thrombosis and pulmonary embolism. […] Hormone replacement therapy or oral contraceptives increase the risk of developing blood clots and pulmonary embolism, especially if you smoke or are overweight.
  • #58 Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/0301/p295.html
    Pulmonary embolism and deep venous thrombosis are the two most important manifestations of venous thrombo-embolism (VTE), which is the third most common life-threatening cardiovascular disease in the United States. […] Current guidelines recommend anticoagulation for a minimum of three months. […] If there are no contraindications, patients diagnosed with acute VTE should receive anticoagulation for a minimum of three months. […] Long-term anticoagulation reduces the risk of recurrent VTE but results in more bleeding events. […] Considering this trade-off, it is critical that the duration of anticoagulation therapy be individualized based on the patient’s risk of recurrence vs. risk of bleeding. […] If a reversible provoking factor is identified as the cause of VTE, anticoagulation beyond three months is not recommended.
  • #59 Treating and Managing Pulmonary Embolism | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-embolism/treating-and-managing
    Treatment is aimed at keeping the blood clot from getting bigger and preventing new clots from forming. […] Blood thinners or anticoagulants are the most common treatment for a blood clot in the lung. […] Patients will normally have to take medications regularly for an indefinite amount of time, usually at least 3 months. […] Appropriate caution must be taken due to the bleeding risk when on anticoagulants. […] Your physician may complete a „hypercoagulability” evaluation on you at some point after your diagnosis.
  • #60 ASH Venous Thromboembolism Guidelines: Treatment of DVT and PE
    https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2020/10/08/15/01/American-Society-of-Hematology-2020-Guidelines
    The ASH guidelines define the treatment period of acute DVT/PE as initial management (first 5-21 days), primary treatment (first 3-6 months), and secondary prevention (beyond the first 3-6 months). The guidelines favor shorter courses of anticoagulation (3-6 months) for acute DVT/PE associated with a transient risk factor. The guidelines suggest indefinite anticoagulation for most patients with unprovoked DVT/PE or a DVT/PE associated with a chronic risk factor. […] The ASH guidelines suggest against the routine use of prognostic scores, D-dimer testing, or venous ultrasound to guide the duration of anticoagulation. […] For patients with DVT/PE with stable cardiovascular disease, the ASH guidelines suggest suspending aspirin therapy when initiating anticoagulation. The combination of anticoagulation plus aspirin increases the risk of bleeding without clear evidence of benefit for patients with stable cardiovascular disease. […] For patients with acute DVT who are not at high risk for post-thrombotic syndrome, the ASH guidelines recommend against the routine use of compression stockings. However, select patients may benefit from compression stockings to help with edema and pain associated with acute DVT.
  • #61 Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/0301/p295.html
    Extended anticoagulation is recommended for patients with an unprovoked VTE and low risk of bleeding. […] Indefinite anticoagulation is recommended for patients with a second VTE and low or moderate risk of bleeding. […] The risk of VTE recurrence is greatest in the first year after the event and remains elevated indefinitely compared with the general population. […] The d-dimer test has been used to stratify risk of recurrent VTE. […] However, the ACCP does not recommend its routine use to determine appropriate candidates for indefinite anticoagulation. […] For patients with low-risk subsegmental PE without proximal DVT, clinical surveillance is preferred over anticoagulation.
  • #62 Deep Vein Thrombosis and Pulmonary Embolism: Awareness and Prophylaxis Practices Reported by Recently Hospitalized Patients – SHM Abstracts | Society of Hospital Medicine
    https://shmabstracts.org/abstract/deep-vein-thrombosis-and-pulmonary-embolism-awareness-and-prophylaxis-practices-reported-by-recently-hospitalized-patients/
    Of the 500 patients surveyed, mean age was 52.5 years (range, 20-801 years), and 64% were female. […] About half of all respondents (46%) reported that their doctor or health care professional did not discuss the risk of DVT or blood clots related to hospitalization. […] Fewer than one third of all respondents report DVT prophylaxis with either an anticoagulant pill or anticoagulant injection. […] DVT prophylaxis reported by respondents included: 63%, ambulation; 39%, compression stockings; 37%, mechanical compression; 37%, aspirin; 29%, anticoagulant injection; 28%, anticoagulant pill. […] Interventions in the hospital setting are needed to improve patient understanding and awareness to optimize DVT prophylaxis and to reduce the related incidence of morbidity and mortality associated with DVT/PE among hospitalized patients.
  • #63 Pulmonary Embolism | The Foundation to Advance Vascular Cures
    https://www.vascularcures.org/pulmonary-embolism
    Prevention of PE is a lot easier than diagnosis or treatment. Therefore, when hospitalized, it is important to ask your health care providers what measures are being taken to prevent PE. These can include the use of graduated compression stockings or prescription of low doses of blood thinners such as unfractionated heparin, low molecular weight heparin, or fondaparinux. […] Dr. Galson laid out recommendations for the prevention of these two common, yet deadly major public health threats, deep vein thrombosis (DVT) and pulmonary embolism (PE). The Call to Action urges a coordinated, multifaceted plan to reduce the number of cases of deep vein thrombosis and pulmonary embolism nationwide. The plan emphasizes the need for: […] Increased awareness about deep vein thrombosis and pulmonary embolism. […] Evidence-based practices for deep vein thrombosis. […] More research on the causes, prevention, and treatment of DVT.
  • #64
    https://scholars.duke.edu/publication/1619066
    Venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common, preventable perioperative complication occurring in up to 5% on noncardiac surgical patients. […] Prevention and treatment of venous thromboembolism is therefore exceedingly important. The risks and benefits of utilizing both mechanical and/or chemoprophylaxis must be weighed for each patient, with certain patient populations requiring special considering. This review covers the current guidelines for prescribing DVT prophylaxis and for treating known cases of both DVT and PE.